Chemotherapy regimens in early breast cancer: Major controversies and future outlook. Expert Rev. Anticancer Ther. 2013, 13, 165-178.Joerger M, Thurlimann B. Chemotherapy regimens in early breast cancer: major controversies and future outlook. Expert Rev Anticancer Ther 2013;13(2):165-178....
An analysis of 29 chemotherapeutic trials in 18 male patients with advanced breast cancer disclosed an overall response rate of 44%. Most of these chemotherapeutic trials consisted of single-agent regimens, namely, fluorouracil, methotrexate, thiotepa, cyclophosphamide, and melphalan. Our data suggest ...
Chemotherapy works by interfering with the ability of rapidly growing cells, which include cancer cells, to divide or multiply.1These powerful drugs target cancer growth by disrupting their DNA or protein production, preventing cell division, and starving them of nutrients. Most of an adult's norma...
Tailored Chemotherapy Regimens Based On Genetic Profiling Targeted Therapies For HER2-positive Breast Cancer Targeting DNA Repair Mechanisms In TNBC The Role Of Patient Advocacy In Breast Cancer Research Treatment Options For Metastatic Breast Cancer Tumor Heterogeneity In Breast Cancer Tumor-Infiltrating Lymp...
Breast Cancer Survivorship Care Variations Between Adjuvant Chemotherapy RegimensBackgroundTreatment-related toxicity can vary subsClinical breast cancer
performed CEA of breast cancer chemotherapy, comparing anthracycline-based regimens to non-anthracycline-based regimens. They found the anthracycline-based regimen to have 12.05 QALY with total treatment cost of $119,055 and the non-anthracycline-based regimen to have 9.56 QALY with total treatment ...
Women who are given chemotherapy often experience symptoms of menopause, such as hot flashes, vaginal dryness, and irregular menstrual cycles. These symptoms are not uncommon and can often be managed adequately with many different regimens. Any of these changes should be discussed with the physician...
In advanced breast cancer, chemotherapy regimens make the cancer shrink or disappear in about 30-60% of people treated. Standard chemotherapy r 30、egimens include: AT: Adriamycin and Taxotere AC T: Adriamycin and Cytoxan, with or without Taxol or Taxotere TAC: Taxotere, Adriamycin, and Cytoxan...
Adjuvant chemotherapy significantly minimized the recurrence risk of breast cancer, and different chemotherapy regimens are estimated to be responsible for a reduction of 35%-60% in the mortality3. However, many studies have reported cognitive impairments following the process of adjuvant chemotherapy in...
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Comparisons between different polychemotherapy regimens for early Breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. The Lancet. 2012;379(9814):432–44. Article Google Scholar Bines J, Kestel...